Onye nrụpụta a pụrụ ịdabere na ya

Ụgwọ nke ụlọ ọrụ Jiangsu Jingye Pharmaceutical Co., Ltd.
ibe_banner

Akụkọ

Ịchọta uru multifunctional nke dibenzocycloheptanone: ilebakwu anya na ngwa ya

N'ihe gbasara kemịkalụ ọgwụ, ogige ole na ole pụtara maka ngwa ha dị iche iche na ịdị irè dị ka dibenzosuberone. Ngwakọta a pụrụ iche, nke a makwaara dị ka 1011-dihydrodibenzo[a,d] cyclohepten-5-one, dọtara uche maka ike ọgwụgwọ ya n'akụkụ dị iche iche nke ọgwụ. Ka anyị banye miri emi n'ime ụwa dibenzosuberone wee nyochaa uru ya na ịghọ akụkụ dị mkpa nke nlekọta ahụike ọgbara ọhụrụ.

N'ihu nyocha ahụike, dibenzosuberone na-egosipụta ihe onwunwe nke na-abawanye uru ya. A maara ya maka ikike ya ime ihe dị ka prodrug, nke pụtara na enwere ike ịtụgharị ya ka ọ bụrụ ndị na-ahụ maka ọgwụ na-arụ ọrụ n'ime ahụ. Ihe onwunwe a pụrụ iche na-enyere aka ahaziri mmetụta ọgwụgwọ ma na-ebelata mmetụta ndị dị n'akụkụ, na-eme ka ọ bụrụ nhọrọ mbụ maka mmepe ọgwụ.

Ngwa ọgwụgwọ nke dibenzocycloconone dị oke mbara ma gbasaa ọtụtụ ngalaba ọgwụ. Nke kacha mkpa n'ime ihe ndị a bụ ọrụ ọ na-arụ n'ịgwọ ọrịa akwara ozi. Nnyocha na-egosi na dibenzosuberone nwere ike inye aka belata mgbaàmà ndị metụtara ọnọdụ dịka ọrịa Parkinson, ọ pụkwara inye aka na nchịkwa dopamine. Na mgbakwunye, enyochala ihe ndị nwere ike igbochi mgbakasị ahụ, na-atụ aro enwere ike iji ya na ọgwụgwọ Akwụkwụ.

Ọzọkwa, a na-amụkarị mmetụta mgbochi mkpali nke dibenzosuberone, na-emepe ohere nke iji ya na-agwọ ọrịa ndị na-egbuke egbuke. Site na ọrịa ogbu na nkwonkwo ruo na ọrịa autoimmune, ikike onyinye a nwere imezi nzaghachi mgbochi ọrịa nwere ike ibute nnukwu ọganihu ọgwụgwọ.

Na mgbakwunye na nke a, dibenzosuberone nwekwara ojiji na endocrinology. Ikike ya na usoro homonụ nke anụ ahụ na-emekọrịta ihe na-egosi na ọ na-ekere òkè n'ịhazi usoro dị ka metabolism na ume homeostasis. Ihe omume a sara mbara na-egosiputa mgbanwe na mkpa dibenzosuberone dị na kemistri ọgwụ nke oge a.

Uru nke dibenzocycloconone na-agbatị karịa mmetụta ọgwụgwọ ya. A na-agbanwe usoro kemịkalụ ya n'ụzọ dị mfe, na-enye ndị na-eme nchọpụta ohere ịmepụta ihe nrụpụta nwere arụmọrụ ka mma ma ọ bụ mmetụta ezubere iche. Mgbanwe a na nhazi na ngwa na-eme ka ọ bụrụ ngwá ọrụ bara uru maka nchọpụta na mmepe ọgwụ.

Maka ndị na-achọ dibenzocycloheptanone dị elu, Jingye Pharmaceutical na-enye ngwọta a pụrụ ịdabere na ya. Webụsaịtị ha nahttps://www.jingyepharma.com/dibenzosuberone-1011-dihydrodibenzoadcyclohepten-5-one-product/na-enye ozi zuru oke gbasara ogige a nwere ọtụtụ akụkụ. Jingye Pharmaceuticals na-agba mbọ ka ọ dị mma ma nwee akụkọ ihe mere eme nke imepụta ọgwụ dị elu, na-eme ka ị nweta ohere dị mma na ntụkwasị obi na dibenzocycloheptanone.

Na nchịkọta, dibenzosuberone gosipụtara ọganihu ọhụrụ na sayensị ọgwụ. Ngwa ya sara mbara, site na neurology ruo endocrinology, na ike ya maka ịhazi ya emeela ka ọ bụrụ isi nkuku nke ọgwụgwọ ọgbara ọhụrụ. Ka anyị na-aga n'ihu na-enyocha omimi nke onyinye a dị ịrịba ama, uru nke dibenzosuberone ga-eme ka ọdịnihu dịkwuo mma na nlekọta ahụike.

Gaa letaJingyePharmaceuticals taa ka ịmatakwu banyere ọganihu ọganihu emere na dibenzosuberone wee mụta ka onyinye a nwere ike gbanwee nghọta gị nke mmepụta ọgwụ.


Oge nzipu: Mar-29-2024